538 results
·
33ms
·
Sources: EU EUDAMED, US FDA
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY ANTI-C-KIT (9.7) RABBIT MONOCLONAL PRIMARY ANTIBODY
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS/LLIAC/VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·VENTANA PATHWAY ANTI-C-KIT PRIMARY ANTIBODY (POLYCLONAL)
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY ANTI-C-KIT (9.7) PRIMARY ANTIBODY
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY Anti-c-KIT (9.7) Primary Antibody
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (VENOUS) ENDOPROSTHESIS UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (VENOUS) ENDOPROTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY ANTI-C-KIT (9.7.) RABBIT MONOCLONAL PRIMARY ANTIBODY
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY ANTI-C-KIT PRIMARY ANTIBODY
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS AND VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT RP ENDOPROSTHESIS VENOUS
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY ANTI-C-KIT (9.7) RABBIT MONOCLONAL PRIMARY ANTIBODY
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Venous Wallstent and Wallstent Venous Endoprosthesis with Unistep Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY Anti-c-KIT (9.7) Primary Antibody
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent Venous Endoprosthesis with Unistep Plus Delivery System
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·PATHWAY Anti-c-KIT (9.7) Primary Antibody